Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Cucurbitacin I: From STAT3 Probe to Translation
2026-08-24
Cucurbitacin I, also known as JSI-124, is most valuable as a causal STAT3 perturbation tool rather than a standalone cytotoxicity reagent. This thought-leadership guide shows how to connect pathway engagement with phenotype, model complexity, and translational decision-making while using a human SAN-plexus assembloid study as a disciplined lesson in biological context.
-
HOBt: From Coupling Fidelity to Translational Design
2026-08-24
HOBt is more than a conventional coupling additive: it is a strategic control point for amide bond formation, stereochemical fidelity, and medicinal chemistry decision-making. Using an indazole- and indole-based glucagon receptor antagonist study as an anchor, this article connects reaction mechanism with SAR quality, preclinical interpretation, and practical reagent management.
-
GLP-1 (9-36) amide: Reliable GLP-1R Assays
2026-08-23
This scenario-based guide explains how GLP-1 (9-36) amide, SKU B5404, can support controlled GLP-1 receptor signaling research while addressing peptide solubility, assay interpretation, and handling risks. It connects product specifications with published evidence on cAMP-based GLP-1R pharmacology and practical cell-based workflow design.
-
BOP Reagent: Reliable Peptide Coupling
2026-08-22
Learn how BOP reagent supports controlled carboxyl group activation and amide bond formation upstream of cell viability and cytotoxicity assays. This scenario-based guide explains handling, solvent compatibility, data interpretation, and vendor selection for SKU A7015.
-
Sulfo-NHS-SS-Biotin for AML Surface Proteomics
2026-08-22
Sulfo-NHS-SS-Biotin enables cell-impermeant surface labeling, reversible affinity capture, and disulfide-based release in one workflow. This guide translates recent AML cell-surface biology into practical enrichment, validation, and troubleshooting strategies for protein purification and surface proteomics.
-
Canagliflozin Hemihydrate: Research Workflows
2026-08-21
Build more reproducible SGLT2 experiments with a practical workflow for Canagliflozin hemihydrate, from solvent preparation and glucose-transport assays to pathway-specific controls. The article also shows how a drug-sensitized yeast platform can serve as a valuable mTOR counter-screen without confusing metabolic activity with TOR inhibition.
-
BIBP 3226: A Causal Probe for Cardiac Arrhythmia
2026-08-20
BIBP 3226 trifluoroacetate provides a defined pharmacological probe for separating NPY Y1 and NPFF signaling in mechanistic studies. This article translates the adipose-neural arrhythmia model into practical assay logic, controls, and interpretation strategies.
-
Brassinolide for Reproducible Cell Assays
2026-08-20
This scenario-driven guide explains how Brassinolide, SKU A3265, can be incorporated into cell viability, proliferation, and apoptosis workflows without confusing solvent effects with biological activity. It covers formulation, assay controls, interpretation of PC-3 apoptosis evidence, and practical product-selection criteria for biomedical laboratories.
-
ATP Solution for mRNA-LNP Workflows
2026-08-19
Discover how a high-purity ATP Solution supports IVT mRNA production, kinase validation, ligation, and phosphorylation assays connected to localized p21 mRNA-LNP research. Practical dilution guidance, workflow controls, and troubleshooting help translate Adenosine-5'-triphosphate handling into more reproducible molecular biology experiments.
-
Cationic Lipid Pairs Redirect mRNA LNPs to the Lung
2026-08-19
Zeng and colleagues developed a cationic lipid pair strategy that combines a liver-targeted ionizable lipid with its quaternary ammonium derivative to shift four-component lipid nanoparticles from liver-biased toward lung-enriched mRNA delivery. The study shows that parent-lipid performance is an important design criterion and that the approach can be extended to clinically used ionizable lipids, including SM-102 and ALC-0315.
-
Z-VDVAD-FMK for Caspase-2 Apoptosis Workflows
2026-08-18
Z-VDVAD-FMK helps researchers test whether caspase-2 contributes to mitochondrial and nuclear apoptosis, while its activity against caspases-3 and -7 requires careful interpretation. This workflow guide connects inhibitor treatment with caspase activity measurement, cytochrome c analysis, DDX23 signaling, and orthogonal cell-death readouts.
-
Triacetin Workflows for Cell and Metabolic Assays
2026-08-18
Triacetin supports distinct workflows spanning glioblastoma apoptosis assays, metabolic regulation studies, and ocular formulation safety testing. This guide converts product-specific concentration, solubility, and dosing information into practical assay designs with controls, optimization checkpoints, and troubleshooting strategies.
-
Standardized Whole-Blood Stimulation for Immunometabolism
2026-08-17
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with targeted metabolic interventions to measure cytokine responses in a physiologically complex system. The approach improves comparability across cohort studies and helps define how glycolysis, fatty-acid oxidation, and other metabolic pathways selectively shape immune activation.
-
Thioredoxin Control of CHK1 Inhibitor Sensitivity
2026-08-17
The reference study identifies thioredoxin 1 as a determinant of checkpoint kinase 1 inhibitor sensitivity in non-small cell lung cancer and links this response to redox recycling of ribonucleotide reductase subunit RRM1. Its findings support a mechanistically focused combination strategy in which thioredoxin reductase inhibition disrupts deoxynucleotide production and reinforces replication-stress–based cancer therapy.
-
SB 431542: Practical ALK5 Inhibitor Workflows
2026-08-16
SB 431542 provides selective control of ALK5-linked TGF-β signaling for mechanistic studies spanning stem-cell organoids, glioma models, and immune assays. This guide translates its Smad2-focused mechanism into practical dosing, validation, troubleshooting, and experimental-design strategies.